246 related articles for article (PubMed ID: 11349883)
1. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
4. [A case of recurrent malignant glioma treated by superselective intraarterial chemotherapy with a combination of etoposide and cisplatin].
Nakagawa H; Kubo S; Fujita T; Tsuruzono K; Miyawaki Y; Arita N; Hayakawa T
Gan To Kagaku Ryoho; 1992 Feb; 19(2):237-40. PubMed ID: 1736836
[TBL] [Abstract][Full Text] [Related]
5. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report.
Nakagawa H; Fujita T; Kubo S; Tsuruzono K; Yamada M; Tokiyoshi K; Miyawaki Y; Kanayama T; Kadota T; Hayakawa T
Surg Neurol; 1994 Jan; 41(1):19-27. PubMed ID: 8310382
[TBL] [Abstract][Full Text] [Related]
6. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
Rajkumar SV; Buckner JC; Schomberg PJ; Reid JM; Bagniewski PJ; Ames MM; Cascino TL; Marks RS
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):969-75. PubMed ID: 9869217
[TBL] [Abstract][Full Text] [Related]
9. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
Shaw EG; Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JR; Foote RL; Su JQ; Schaid DJ; Lee RE
Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN; Smith A; Foreman N; Bouffet E
Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Beppu T; Yoshida Y; Arai H; Wada T; Suzuki M; Ogawa A; Hakozaki S; Kubo N
J Neurooncol; 2000 Sep; 49(3):213-8. PubMed ID: 11212900
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Fulton D; Urtasun R; Forsyth P
J Neurooncol; 1996 Feb; 27(2):149-55. PubMed ID: 8699237
[TBL] [Abstract][Full Text] [Related]
16. [Intraarterial chemotherapy using a combination of etoposide and cisplatin for recurrent malignant lymphoma].
Hirayama A; Nakagawa H; Maeda N; Tsuzuki T; Yamamoto H; Kadota T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2135-40. PubMed ID: 9838920
[TBL] [Abstract][Full Text] [Related]
17. Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.
Chamberlain MC
Arch Neurol; 1997 May; 54(5):554-8. PubMed ID: 9152112
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.
van den Bent MJ; Pronk L; Sillevis Smitt PA; Vecht CJ; Eskens FA; Verweij J
J Neurooncol; 1999 Aug; 44(1):59-64. PubMed ID: 10582670
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
Chewaskulyong B; Thongprasert S
J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors.
Strauss LC; Killmond TM; Carson BS; Maria BL; Wharam MD; Leventhal BG
Med Pediatr Oncol; 1991; 19(1):16-21. PubMed ID: 1990253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
